CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

How Machine Learning is Impacting Clinical Trials

How Machine Learning is Impacting...

Clasado Biosciences Joins Lucie Nagy as Head of Regulatory and Legal

Clasado Biosciences Joins Lucie Nagy...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

Major Challenges Facing Life Science and Pharmaceutical Supply Chains

Major Challenges Facing Life Science...

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

The Importance of Bioanalytical Method Validation

The Importance of Bioanalytical...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

How Machine Learning is Impacting Clinical Trials

How Machine Learning is Impacting...

Clasado Biosciences Joins Lucie Nagy as Head of Regulatory and Legal

Clasado Biosciences Joins Lucie Nagy...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

Major Challenges Facing Life Science and Pharmaceutical Supply Chains

Major Challenges Facing Life Science...

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

The Importance of Bioanalytical Method Validation

The Importance of Bioanalytical...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

Significance of Bioanalytical Studies

Life Sciences Review | Thursday, September 02, 2021
Tweet

Bioanalytical assays offer information on some safety aspects of the clinical regimen to assess the maximum tolerated dosage.


FREMONT, CA: Bioanalytical studies are a significant part of biologic drug production since results from these studies are required to identify the characteristics of possible new biologics. Bioanalysis data is also an essential inclusion in regulatory filings, prompting the need for outsourcing partners with in-depth bioanalytical expertise and experience engaging with regulatory authorities.


Why is it so necessary to carry out bioanalytical studies during the creation of a new biotherapeutic? Bioanalytical tests, which are intended to include assessments of the concentration of drugs and biologics in pre-clinical and clinical studies of the therapeutic molecule or its metabolites, are important to different areas of human clinical pharmacology, Bioavailability (BA)/ Bioequivalence (BE) studies, and certain non-clinical studies involving concentration knowledge for pharmacology. Bioanalytical work is intended to accompany pivotal trials and assist in the decision-making process for the acceptance, efficacy, and classification of medicines or biologics; in brief, without adequate bioanalytical results, the therapeutic substance will not be approved.


Beyond the regulatory criteria for performing bioanalytical studies, the scientific value of the data produced by these assays is priceless. Bioanalytical assays offer information on some safety aspects of the clinical regimen to assess the maximum tolerated dosage. Pharmacokinetics (PK) scientists use the data to evaluate exposure, half-life, and other pharmacological criteria used to direct decisions about how much and how long care can be provided for effectiveness without excessive toxicity.


Bioanalytical assays range beyond merely calculating drug concentrations over time but are also used to determine drug effectiveness using Pharmacodynamic (PD) endpoints (i.e., biomarkers). (i.e., biomarkers). The findings of the biomarker assay could provide early indicators of effectiveness or even safety concerns. They may also be used to stratify patients to predict respondents or non-responders. The determination of immunogenicity is another critical bioanalytical assay for biotherapy (both wanted and unwanted). A good immunogenicity test can be viewed as possible proof that the vaccine is functioning as expected to develop the vaccine. Unwanted immunogenicity is even more complicated since anti-drug antibodies' effect may have an impact on the pharmacokinetics, effectiveness, and safety of anti-drugs and should be considered at the specific patient level.


Weekly Brief

loading
Top 10 Bioanalytical Services Companies in Apac - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/significance-of-bioanalytical-studies-nwid-219.html